Effects of PH3 in Diabetic Nephropathy

Summary

The primary objective of this clinical study is to evaluate the effectiveness and safety of PH3 for patients with diabetic nephropathy. The secondary objectives are to identify the optimal dosage for subsequent studies and to provide basis for the next confirmatory study in study design, endpoints, and study methodologies.

Timeline

Start

2010-08

Primary completion

2014-07

Completion

2015-09

Drugs

Indications